Nanjing Well Pharmaceutical

Nanjing Well Pharmaceutical Group Co., Ltd. is a leading Chinese specialty pharmaceutical company focused on the development, manufacturing, and commercialization of pharmaceutical excipients and active pharmaceutical ingredients (APIs). Established in 2000 and headquartered in Nanjing, the company provides essential chemical components for a wide range of drug delivery systems including injectable, oral, and topical formulations. Their extensive product portfolio includes Polysorbate (Tween) series, Sorbitan fatty acid esters (Span), and various Polyethylene Glycols, serving over 1,000 global pharmaceutical partners like GSK and Novartis. Nanjing Well Pharmaceutical is a publicly traded entity on the Shanghai Stock Exchange and maintains several GMP-compliant, highly automated production facilities. Beyond its core pharmaceutical business, the group operates subsidiaries in biotechnology and synthetic lubricants, emphasizing high-purity chemical synthesis and innovative material science for healthcare applications.